A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This essential tumor inhibitor protein is frequently inactivated in various forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research